Current and emerging treatments for sickle cell disease

Area of Science:

• Hematology
• Genetics
• Internal Medicine

Background:

• Sickle cell disease (SCD) is a group of inherited blood disorders.
• It affects hemoglobin, leading to shortened erythrocyte lifespan and sickled cell shapes.
• These sickled cells can cause vaso-occlusion, a hallmark complication.

Purpose of the Study:

• To review the disease process of sickle cell disease.
• To outline typical clinical presentations and complications.
• To discuss current acute and chronic treatment strategies.

Main Methods:

• Literature review of sickle cell disease.
• Analysis of disease mechanisms and pathophysiology.
• Synthesis of current therapeutic approaches.

Main Results:

• SCD is characterized by abnormal hemoglobin leading to sickled erythrocytes.
• Vaso-occlusion is a primary cause of morbidity and mortality.
• Current treatments include hydroxyurea, erythrocyte transfusions, and stem cell transplantation.

Conclusions:

• Understanding the disease process is crucial for effective management.
• Comprehensive treatment strategies are necessary to address SCD complications.
• Ongoing research aims to improve therapeutic outcomes for sickle cell disease patients.